Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling.

BMC medical genomics - 18 Feb 2015

Foster Joseph M, Oumie Assa, Togneri Fiona S, Vasques Fabiana Ramos, Hau Debra, Taylor Morag, Tinkler-Hundal Emma, Southward Katie, Medlow Paul, McGreeghan-Crosby Keith, Halfpenny Iris, McMullan Dominic J, Quirke Phil, Keating Katherine E, Griffiths Mike, Spink Karen G, Brew Fiona

Abstract excerpt

BACKGROUND: Adoption of new technology in both basic research and clinical settings requires rigorous validation of analytical performance. The OncoScan® FFPE Assay is a multiplexing tool that offers genome-wide copy number and loss of heterozygosity detection, as well as identification of frequently tested somatic mutations. METHODS: In this study, 162 formalin fixed paraffin embedded samples, representing six...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clinical Laboratory Techniques
Share to Genome, Human

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Loss of Heterozygosity

Share to Oligonucleotide Array Sequence Analysis

Share to Paraffin Embedding

Share to Quality Control

Share to Sensitivity and Specificity

Share to Tissue Fixation

Source

Open in PubMed Open full text

Identifiers

PMID: 25889064
DOI: 10.1186/s12920-015-0079-z
PMCID: PMC4342810

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling.PMID 25889064Read ↗

Clinical validation of Whole Genome Sequencing for cancer diagnosticsSemantic proximity Read ↗

An absolute approach to using whole exome DNA and RNA workflow for cancer biomarker testingSemantic proximity Read ↗

Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics.Semantic proximity Read ↗

Multicenter In-House Evaluation of an Amplicon-Based Next-Generation Sequencing Panel for Comprehensive Molecular Profiling.Semantic proximity Read ↗

Validation and Clinical Application of ONCOaccuPanel for Targeted Next-Generation Sequencing of Solid Tumors.Semantic proximity Read ↗

TumorNext: A comprehensive tumor profiling assay that incorporates high resolution copy number analysis and germline status to improve testing accuracy.Semantic proximity Read ↗

Analytical Validation and Clinical Utilization of the Oncomine Comprehensive Assay Plus Panel for Comprehensive Genomic Profiling in Solid TumorsSemantic proximity Read ↗

Single-Center Experience with a Targeted Next Generation Sequencing Assay for Assessment of Relevant Somatic Alterations in Solid Tumors.Semantic proximity Read ↗

Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer.Semantic proximity Read ↗

Comparative Lesions Analysis Through a Targeted Sequencing Approach.Semantic proximity Read ↗

Development and Validation of StrataNGS, a Multiplex PCR, Semiconductor Sequencing-Based Comprehensive Genomic Profiling TestSemantic proximity Read ↗

FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.